ORIGINAL RESEARCH article
Front. Immunol.
Sec. Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1597862
This article is part of the Research TopicMathematical Modeling in Discovery and Analysis of Immune ResponsesView all 8 articles
Optimized Network Inference for Immune Diseased single cells (ONIDsc)
Provisionally accepted- 1Systems Biology Ireland, School of Medicine, College of Health and Agricultural Sciences, University College Dublin, Dublin, Ireland
- 2Department of Genetics, Faculty of Science, University of Granada, 18071, Granada, Spain., Granada, Spain
- 3Pfizer–University of Granada–Junta de Andalucía Centre for Genomics and Oncological Research, Granada, Spain, Granada, Spain
- 4Bioinformatics Laboratory, Centro de Investigación Biomédica, Biotechnology Institute, PTS, Avda del Conocimiento S/N, 18100, Granada, Spain., Granada, Spain
- 5GENYO, Centre for Genomics and Oncological Research Pfizer, University of Granada, Andalusian Regional Government, PTS Granada, Granada, Spain., Granada, Spain
- 6Institute of Environmental Medicine, Karolinska Institutet (KI), Stockholm, Stockholm, Sweden
- 7Conway Institute of Biomolecular & Biomedical Research, University College Dublin, Belfield, Dublin 4, Ireland, Dublin, Ireland
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Mathematical models are powerful tools that can be used to advance our understanding of complex diseases. Autoimmune disorders such as Systemic lupus erythematosus (SLE) are highly heterogeneous and require high-resolution mechanistic approaches. In this work, we present ONIDsc, a single-cell regulatory network inference model designed to elucidate immune-related disease mechanisms in SLE. ONIDsc enhances the GLG causality model used in SINGE by finding the optimal lambda penalty with cyclical coordinate descent. We benchmarked ONIDsc against existing models and found it consistently outperforms SINGE and other methods when gold standards are generated from ChIP-seq and ChIP-chip experiments. We then applied ONIDsc to three large-scale datasets, one from control patients and the two from SLE patients, to reconstruct networks common to different immune cell types. ONIDsc identified four gene transcripts: MXRA8, NADK, POLR3GL and UBXN11 in CD4TCs, CD8TREGs, CD8TC1s and LDGs that were present in SLE patients but absent in controls in controls. These genes were significantly related to nicotinate metabolism, RNA transcription, protein phosphorylation and the RND 1-3 signaling pathways, previously associated with immune regulation. Our results highlight ONIDsc's potential as a powerful tool for dissecting physiological and pathological processes in immune cells using high-dimensional single-cell data.
Keywords: Network Inference, lupus(SLE), single-cell, mathematical modeling, gene marker.
Received: 21 Mar 2025; Accepted: 25 Jun 2025.
Copyright: © 2025 Tejero, Vaz, Barturen, Rivas-Torrubia, Alarcon-Riquelme, Kolch and Matallanas. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: David Matallanas, Systems Biology Ireland, School of Medicine, College of Health and Agricultural Sciences, University College Dublin, Dublin, Dublin 4, Ireland
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.